COVID-19 Updates

Visit UC San Diego's Coronavirus portal for the latest information for the campus community.

Dr. Kathryn Gold Named Co-Director of ACTRI Clinical Research Services

Kathryn A. Gold, MD

August 3, 2018 – UC San Diego Altman Clinical and Translational Research Institute (ACTRI) is pleased to announce the appointment of Kathryn A. Gold, MD, as co-director of the ACTRI Division of Clinical Research Services (CRS), effective immediately. In her new role, Dr. Gold will co-lead the CRS with Mark S. Wallace, MD, who has served as director of the division since 2010. Dr. Gold joined ACTRI as associate director of CRS in July, 2017.

“Dr. Gold has done an outstanding job as associate director of the clinic for the past year, making a significant impact on how we provide clinical research services. I am excited she has accepted the position of co-director,” said Gary S. Firestein, MD, director of ACTRI and dean and associate vice chancellor for clinical and translational medicine. “An accomplished oncologist and investigator, she will continue working closely with Dr. Wallace, as the ACTRI clinical research activities grow.”

In her new role at ACTRI, Dr. Gold will co-direct the day-to-day functions of the unit, which manages a dedicated research clinic, voucher applications, and the Scientific Review Committee. The research clinic includes 18,000 square feet of state-of-the-art facilities to support all phases of clinical research and presently supports nearly 300 clinical research projects each year.

Dr. Gold is an associate professor at UC San Diego Department of Medicine and board-certified in internal medicine and medical oncology. Her clinical and translational research interests include lung and head and neck cancer, with a focus on target therapies and immunotherapies.

Prior to joining UC San Diego Health, Dr. Gold was an assistant professor in the Department of Thoracic/Head and Neck Medical Oncology at The University of Texas MD Anderson Cancer Center in Houston. Dr. Gold completed a fellowship in medical oncology at MD Anderson Cancer Center, where she was selected for her clinical and leadership abilities to serve as chief fellow. She completed a residency in internal medicine at Hospital of the University of Pennsylvania in Philadelphia. Dr. Gold received her medical degree from Washington University School of Medicine in St. Louis.

Dr. Gold has presented her work at both national and international medical conferences. She has coauthored many articles, and her research has appeared in The Lancet Oncology, the Journal of the National Cancer Institute, and The New England Journal of Medicine, among others. She is a member of the American Society of Clinical Oncology, the American Association of Cancer Research and the International Association for the Study of Lung Cancer.

About UC San Diego Altman Clinical and Translational Research Institute:

UC San Diego Altman Clinical and Translational Research Institute (ACTRI) is part of a national Clinical and Translational Science Award consortium, led by the National Institutes of Health National Center for Advancing Translational Science. Established in 2010, ACTRI provides infrastructure and support for basic, translational and clinical research throughout the San Diego region to bring discoveries from the laboratory to the bedside, and facilitates training and education of the next generation of researchers. ACTRI carries out its activities in collaboration with institutional and corporate partners and currently has more than 1,500 members.